ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat.
Meidhof S, Brabletz S, Lehmann W, Preca BT, Mock K, Ruh M, Schüler J, Berthold M, Weber A, Burk U, Lübbert M, Puhr M, Culig Z, Wellner U, Keck T, Bronsert P, Küsters S, Hopt UT, Stemmler MP, Brabletz T.
Meidhof S, et al. Among authors: kusters s.
EMBO Mol Med. 2015 Jun;7(6):831-47. doi: 10.15252/emmm.201404396.
EMBO Mol Med. 2015.
PMID: 25872941
Free PMC article.